Viewing Study NCT00808301



Ignite Creation Date: 2024-05-05 @ 9:04 PM
Last Modification Date: 2024-10-26 @ 9:59 AM
Study NCT ID: NCT00808301
Status: UNKNOWN
Last Update Posted: 2015-03-18
First Post: 2008-12-12

Brief Title: Oat Products in the Treatment of Coeliac Disease in Children
Sponsor: Heinz Italia SpA
Organization: Heinz Italia SpA

Study Overview

Official Title: Multicentre Clinical Trial on Oat Products in the Treatment of Coeliac Disease in Children
Status: UNKNOWN
Status Verified Date: 2015-03
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years

The purpose of this study is to evaluate clinical tolerance and liking of gluten-free products containing oatmeal from a specific oat variety not contaminated with gluten in a sample of Italian celiac patients in pediatric age
Detailed Description: Several clinical trials have demonstrated that most celiac patients both of pediatric and of adult age can take medium-high quantity of oat 50-100 gday without any negative clinical effects

In a small number of cases intestinal dyspeptic disorders especially meteorism can be observed particularly during the first weeks of oat intake They are generally without clinical significance because they are a consequence of the increased fibre intake

There are only few cases of true oats intolerance The addition of oat improves the nutritional quality of the gluten-free diet particularly due to the increased intake of fibre and some oligoelements iron zinc tiamin pholates and expands the spectrum of food choices

In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years

For the oat-based product to be considered suitable in the dieto-therapy of coeliac disease the absence of gluten contamination and possibly the origin from a variety of oat which is without traces of gluten cross-reactive peptides must be guaranteed

The purpose of this study is to evaluate clinical tolerance and liking of gluten-free products containing oatmeal from a specific oat variety not contaminated with gluten in a sample of Italian celiac patients in pediatric age

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None